These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31624299)

  • 1. Loss of TIMP3 by promoter methylation of Sp1 binding site promotes oral cancer metastasis.
    Su CW; Chang YC; Chien MH; Hsieh YH; Chen MK; Lin CW; Yang SF
    Cell Death Dis; 2019 Oct; 10(11):793. PubMed ID: 31624299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peperomin E Induces Promoter Hypomethylation of Metastatic-Suppressor Genes and Attenuates Metastasis in Poorly Differentiated Gastric Cancer.
    Wanga XZ; Gu JL; Gao M; Bian Y; Liang JY; Wen HM; Wu H
    Cell Physiol Biochem; 2018; 50(6):2341-2364. PubMed ID: 30423554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter methylation and expression of TIMP3 gene in gastric cancer.
    Guan Z; Zhang J; Song S; Dai D
    Diagn Pathol; 2013 Jul; 8():110. PubMed ID: 23819566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis.
    Huang HL; Liu YM; Sung TY; Huang TC; Cheng YW; Liou JP; Pan SL
    Theranostics; 2019; 9(22):6676-6689. PubMed ID: 31588243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic Anhydrase III Promotes Cell Migration and Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma.
    Chu YH; Su CW; Hsieh YS; Chen PN; Lin CW; Yang SF
    Cells; 2020 Mar; 9(3):. PubMed ID: 32183030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demethylation of TIMP2 and TIMP3 Inhibits Cell Proliferation, Migration, and Invasion in Pituitary Adenomas.
    Yang Y; Huang F; Wu X; Huang C; Li Y
    Discov Med; 2024 May; 36(184):971-980. PubMed ID: 38798256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter Hypermethylation of Tumor-Suppressor Genes
    Liyanage C; Wathupola A; Muraleetharan S; Perera K; Punyadeera C; Udagama P
    Biomolecules; 2019 Apr; 9(4):. PubMed ID: 31013839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dehydroandrographolide inhibits oral cancer cell migration and invasion through NF-κB-, AP-1-, and SP-1-modulated matrix metalloproteinase-2 inhibition.
    Hsieh MJ; Chen JC; Yang WE; Chien SY; Chen MK; Lo YS; Hsi YT; Chuang YC; Lin CC; Yang SF
    Biochem Pharmacol; 2017 Apr; 130():10-20. PubMed ID: 28131848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells.
    Anania MC; Sensi M; Radaelli E; Miranda C; Vizioli MG; Pagliardini S; Favini E; Cleris L; Supino R; Formelli F; Borrello MG; Pierotti MA; Greco A
    Oncogene; 2011 Jul; 30(27):3011-23. PubMed ID: 21339735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
    Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
    Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of methylation markers for diagnosis of oral cavity cancer.
    Arantes LM; de Carvalho AC; Melendez ME; Centrone CC; Góis-Filho JF; Toporcov TN; Caly DN; Tajara EH; Goloni-Bertollo EM; Carvalho AL;
    Eur J Cancer; 2015 Mar; 51(5):632-41. PubMed ID: 25686481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression.
    Su CW; Su BF; Chiang WL; Yang SF; Chen MK; Lin CW
    Int J Med Sci; 2017; 14(1):37-44. PubMed ID: 28138307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression.
    Kornfeld JW; Meder S; Wohlberg M; Friedrich RE; Rau T; Riethdorf L; Löning T; Pantel K; Riethdorf S
    Br J Cancer; 2011 Jan; 104(1):138-45. PubMed ID: 21102583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: Impact on Genetic Susceptibility and Clinical Outcome of Oral Cancer.
    Su CW; Huang YW; Chen MK; Su SC; Yang SF; Lin CW
    Medicine (Baltimore); 2015 Nov; 94(46):e2092. PubMed ID: 26579821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDM1A promotes tumor cell invasion by silencing TIMP3 in non-small cell lung cancer cells.
    Kong L; Zhang P; Li W; Yang Y; Tian Y; Wang X; Chen S; Yang Y; Huang T; Zhao T; Tang L; Su B; Li F; Liu XS; Zhang F
    Oncotarget; 2016 May; 7(19):27959-74. PubMed ID: 27058897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-1258, regulated by c-Myb, inhibits growth and epithelial-to-mesenchymal transition phenotype via targeting SP1 in oral squamous cell carcinoma.
    Zhang H; Jiang S; Guo L; Li X
    J Cell Mol Med; 2019 Apr; 23(4):2813-2821. PubMed ID: 30734471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
    Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC
    Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
    Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
    Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypomethylation of TIMP3 is associated with pre-eclampsia in a Chinese population.
    Xiang Y; Zhang X; Li Q; Xu J; Zhou X; Wang T; Xing Q; Liu Y; Wang L; He L; Zhao X
    Mol Hum Reprod; 2013 Mar; 19(3):153-9. PubMed ID: 23172037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRH site-specific methylation in oral and oropharyngeal squamous cell carcinoma.
    Puttipanyalears C; Arayataweegool A; Chalertpet K; Rattanachayoto P; Mahattanasakul P; Tangjaturonsasme N; Kerekhanjanarong V; Mutirangura A; Kitkumthorn N
    BMC Cancer; 2018 Aug; 18(1):786. PubMed ID: 30081853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.